<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Beier | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/pantslaw86/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/pantslaw86/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Beier.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">33b9545fca947508973d64b8f77b3d78</guid>
				<title>Beier posted an update: Responsiveness data were only available for the Gross Motor [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/42164/</link>
				<pubDate>Sat, 08 Feb 2025 12:40:25 -0800</pubDate>

									<content:encoded><![CDATA[<p>Responsiveness data were only available for the Gross Motor Function Measure-Challenge battery. The decision tree was developed with five levels clinical feasibility, relevance, tool design, clinical utility, and psychometric properties. INTERPRETATION High-level motor skills assessment tools have strong psychometric evidence for ambulant,&hellip;<span class="activity-read-more" id="activity-read-more-42164"><a href="http://www.nationalboardinstitute.com/activity/p/42164/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">3d5c41e4842d6da5b715924da057627d</guid>
				<title>Beier posted an update: 002). Median pre- and post-treatment CA-125 levels for LGSC [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/40491/</link>
				<pubDate>Thu, 06 Feb 2025 16:48:01 -0800</pubDate>

									<content:encoded><![CDATA[<p>002). Median pre- and post-treatment CA-125 levels for LGSC patients were 295.5U/mL and 144U/mL (52% decrease) (p&lt;0.001). The median pre- and post-treatment CA-125 levels for HGSC patients were 767.5 and 35.6 (96% decrease) (p&lt;0.001). For LGSC patients, 4/36 (11%) had partial response (PR), 30/36 (83%) had stable disease (SD), and 2/36 (6%) had&hellip;<span class="activity-read-more" id="activity-read-more-40491"><a href="http://www.nationalboardinstitute.com/activity/p/40491/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">cf3885763ee63d39ae3410a3289109dd</guid>
				<title>Beier posted an update: The assay for transposase-accessible chromatin followed by [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/39391/</link>
				<pubDate>Wed, 05 Feb 2025 13:02:07 -0800</pubDate>

									<content:encoded><![CDATA[<p>The assay for transposase-accessible chromatin followed by sequencing (ATAC-seq) is an inexpensive protocol for measuring open chromatin regions. ATAC-seq is also relatively simple and requires fewer cells than many other high-throughput sequencing protocols. Therefore, it is tractable in numerous settings where other high throughput assays are&hellip;<span class="activity-read-more" id="activity-read-more-39391"><a href="http://www.nationalboardinstitute.com/activity/p/39391/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">360e1aa909ddc7055e0d42d77c32ffc6</guid>
				<title>Beier posted an update: inib therapy, the median PFS was 7.9 months (95%CI 4.1-11.7 [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/37749/</link>
				<pubDate>Mon, 03 Feb 2025 12:02:48 -0800</pubDate>

									<content:encoded><![CDATA[<p>inib therapy, the median PFS was 7.9 months (95%CI 4.1-11.7 months). Among the 15 patients with brain metastasis, the median PFS was 6.0 months (95%CI 2.2-9.8 months). The main toxicities related to pyrotinib were diarrhea in 57 (79.2%) cases, and 48 (66.7%) cases with grade 1-2 as well as 9 (12.5%) cases with grade 3. CONCLUSION Pyrotinib based&hellip;<span class="activity-read-more" id="activity-read-more-37749"><a href="http://www.nationalboardinstitute.com/activity/p/37749/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">428807936a8b82319c174af3ea0a9611</guid>
				<title>Beier posted an update: The BPS intervention was associated with decreases in both [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/36823/</link>
				<pubDate>Sun, 02 Feb 2025 12:05:39 -0800</pubDate>

									<content:encoded><![CDATA[<p>The BPS intervention was associated with decreases in both the CAR and cortisol responses to acute stress. Compared to controls, BPS participants showed decreased worrying and increased positive affect post-intervention; however, they did not show the expected greater increase in optimism. Within-person decreases in worrying were associated with&hellip;<span class="activity-read-more" id="activity-read-more-36823"><a href="http://www.nationalboardinstitute.com/activity/p/36823/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">af643cbc848ddf1588a28856517fa68f</guid>
				<title>Beier posted an update: The diameter of a micro-tube is very small and its wall [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/35984/</link>
				<pubDate>Sat, 01 Feb 2025 12:09:12 -0800</pubDate>

									<content:encoded><![CDATA[<p>The diameter of a micro-tube is very small and its wall thickness is very thin. Thus, when applying double-layer gas-assisted extrusion technology to process a micro-tube, it is necessary to find the suitable inlet gas pressure and a method for forming a stable double gas layer. In this study, a double-layer gas-assisted extrusion experiment is&hellip;<span class="activity-read-more" id="activity-read-more-35984"><a href="http://www.nationalboardinstitute.com/activity/p/35984/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">05d561e698bddfecba3b29c4a1591cbd</guid>
				<title>Beier posted an update: We studied the effect of an amyloidogenic intrinsically [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/34193/</link>
				<pubDate>Thu, 30 Jan 2025 12:04:33 -0800</pubDate>

									<content:encoded><![CDATA[<p>We studied the effect of an amyloidogenic intrinsically disordered protein, α-synuclein, which is associated with Parkinson&#8217;s disease (PD), on the conformational dynamics of a DNA hairpin (DNA-HP) employing the single-molecule Förster resonance energy transfer method. The open-to-closed conforma-tional equilibrium of the DNA-HP is drastically a&hellip;<span class="activity-read-more" id="activity-read-more-34193"><a href="http://www.nationalboardinstitute.com/activity/p/34193/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">0af618b830a83fc4fcb8fa9409333e9b</guid>
				<title>Beier posted an update: 69% vs 0.87%, respectively). Compared with patients with [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/30899/</link>
				<pubDate>Tue, 28 Jan 2025 15:54:25 -0800</pubDate>

									<content:encoded><![CDATA[<p>69% vs 0.87%, respectively). Compared with patients with SVR, patients without SVR had a significantly higher risk of gastric cancer (0.10% vs 0.03% per person-year, P = 0.004) and non-Hodgkin lymphoma (NHL) (0.08% vs 0.03% per person-year, respectively, P = 0.03). When considering death as a competing risk, non-SVR was independently associated&hellip;<span class="activity-read-more" id="activity-read-more-30899"><a href="http://www.nationalboardinstitute.com/activity/p/30899/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">2f3d939c78737648a496849fcc3c94b2</guid>
				<title>Beier became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/30874/</link>
				<pubDate>Tue, 28 Jan 2025 15:52:27 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>